Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
The summary for the Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional): The purpose of this funding opportunity announcement (FOA) is to encourage small businesses to collaborate with scientists and clinicians in the field of gynecologic health to develop, advance, and validate new devices and methods for non-invasive diagnosis and/or screening of endometriosis, adenomyosis, and/or uterine fibroids. Projects supported will aim to shorten the time to diagnosis, decrease the invasiveness of current techniques, and/or improve accessibility, safety, convenience, and costs of diagnosis and/or screening.
Federal Grant Title: | Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HD-20-019 |
Type of Funding: | Grant |
CFDA Numbers: | 93.865 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | December 10th, 2019 |
Original Application Deadline: | December 10th, 2019 |
Posted Date: | September 17th, 2019 |
Creation Date: | September 17th, 2019 |
Archive Date: | January 15th, 2020 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | September 17th, 2019 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See the funding announcement for eligibility details
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-20-019.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
- • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...
- • Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...
- • Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
- • Biological Testing Facility (X01 Clinical Trial Not Allowed)
- • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)